Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer

Name: Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer
Published: 2015
License: Public Domain

Celgene · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

breastcancer breastneoplasms lungcancer metastaticbreastcancer nsclc paclitaxel pancreaticcancer smallcelllungcancer

breast neoplasms, pancreatic neoplasms, pancreatic cancer, breast cancer, metastatic breast cancer, nab-paclitaxel, gemcitabine, carboplatin, non-small cell lung cancer, lung cancer, mbc, nsclc

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 898458
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.